Gynecologic Cancer
Article
Which birth defects are associated with childhood cancer risk?
Clinical Review
Morcellation use in gynecologic surgery: Current clinical recommendations and cautions
Here, evolving thought on preoperative evaluation and counseling, updated ACOG guidelines, and changes implemented at the authors...
Clinical Review
Office hysteroscopic evaluation of postmenopausal bleeding
Postmenopausal bleeding can indicate endometrial carcinoma. When and how can hysteroscopy make the difference in diagnosis (and...
From the Editor
Why do so many women aged 65 years and older die of cervical cancer?
Many women aged >65 years who are at risk for cervical cancer are not being actively screened, resulting in a high rate of...
Gynecologic Oncology Consult
What is the future of para-aortic lymphadenectomy for endometrial cancer?
Release of the landmark study of advanced endometrial cancer, GOG 258, raises some questions.
Conference Coverage
Ovarian cancer diagnosed and treated earlier under ACA
CHICAGO – Ovarian cancer is more often diagnosed at an earlier stage and treated within 30 days under the ACA, vs. pre-ACA.
From the Journals
Vaginal microbiota composition linked to ovarian cancer risk
In a case-control analysis, women under 50 years of age with ovarian cancer were more likely to have a community type O microbiota relative to age...
From the Journals
Gaps in patient-provider survivorship communication persist
Over a recent 5-year period, there was little change in the percentages of patients who reported not having any detailed discussion with providers...
Conference Coverage
Abnormal uterine bleeding: When can you forgo biopsy?
NASHVILLE, TENN. – Recurrent bleeding and endometrial thickening can help guide the initial approach to evaluating...
News
FDA approves bevacizumab-bvzr for several cancers
The bevacizumab biosimilar is now approved for metastatic colorectal cancer, advanced non-squamous non–small cell lung cancer, recurrent...
From the Journals
Chemoradiotherapy no better than chemo alone in endometrial carcinoma
In a phase 3 trial of patients with stage III or IVA endometrial cancer, the proportion of patients alive and relapse free at 60 months was 59%...